Pharmaceuticals

2025 Cannabis Capsule Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

September 1, 2025 by Marketing Posting

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#What Is the Current and Projected Market Size of the Cannabis Capsule Industry?#_x000D_

The size of the anakinra market has seen significant expansion in the past few years. It’s forecasted to escalate from $4.89 billion in 2024 to $5.46 billion in 2025, with a compound annual growth rate (CAGR) of 11.8%. The surge during the historical period can be traced back to an uptick in the occurrence of rheumatoid arthritis, the acceptance of anakinra for dealing with unusual autoinflammatory diseases like NOMID, increased awareness of biologics for controlling chronic inflammation, and the rising acceptance of targeted therapies._x000D_

_x000D_

In the coming years, the market size of anakinra is projected to experience a significant surge, escalating to “ $8.6 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 12.0%. ” This growth within the forecast span can be credited to factors including the broadening of indications for anakinra usage in various conditions, heightened attention on personalized medicine, an increase in the prevalence of rare autoinflammatory disorders, and advancements in drug delivery systems. The growth is also aided by the rising access to healthcare in budding markets, which bolsters the demand for biologics. During the predicted timeline, we can expect to see prominent trends like the emergence of biosimilars and next-generation IL-1 inhibitors, the rise of home-based and self-administered treatment alternatives, associations between biotech businesses and academic institutions, and the use of digital health solutions for bolstering patient adherence._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=21095&type=smp_x000D_

_x000D_

#Which Factors Are Currently Driving The Growth Of The Cannabis Capsule Market?_x000D_

The growth of the cannabis capsule market is projected to accelerate due to the escalating number of neurological disorders. Neurological disorder is a health issue that impacts the central and peripheral nervous systems, affecting not only the nerves in the spinal cord and body but also the brain. Cannabis capsules, which contain compounds like cannabidiol (CBD), can potentially impressively impact neurological disorders by preventing the development of social recognition memory deficits seen in ailments like Alzheimer’s disease. For example, the World Federation of Neurology, a UK-based collaboration of national neurological societies, reported in October 2023 that over 40% of the global population are presently suffering from some sort of neurological condition. This number is predicted to almost double by 2050. Consequently, the increasing incidence of neurological disorders is fuelling the expansion of the cannabis capsule market._x000D_

_x000D_

The anakinra market covered in this report is segmented – _x000D_

_x000D_

1) By Indication: Rheumatoid Arthritis, Cryopyrin-Associated Periodic Syndromes, Familial Cold Autoinflammatory Syndrome, Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still’s Disease, Neonatal-Onset Multisystem Inflammatory Disease, Other Indications_x000D_

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Wholesale Pharmacies_x000D_

3) By End-User: Hospitals, Clinics, Homecare Settings_x000D_

_x000D_

Subsegments:_x000D_

1) By Rheumatoid Arthritis: Moderate-to-Severe Disease, Early-stage Disease _x000D_

2) By Cryopyrin-Associated Periodic Syndromes: Muckle-Wells Syndrome, Neonatal-Onset Multisystem Inflammatory Disease _x000D_

3) By Familial Cold Autoinflammatory Syndrome: Acute Episodes, Chronic Symptoms _x000D_

4) By Systemic Juvenile Idiopathic Arthritis: Active Systemic Disease, Inactive Disease With Flares _x000D_

5) By Adult-Onset Still’s Disease: Active Disease, Remission Induction _x000D_

6) By Neonatal-Onset Multisystem Inflammatory Disease: Acute Disease Episodes, Long-term Disease Management _x000D_

7) By Other Indications: Gouty Arthritis, Osteoarthritis, Spondyloarthritis_x000D_

_x000D_

#What Long-Term Trends Are Likely To Affect The Cannabis Capsule Market?#_x000D_

Leading firms in the Anakinra market are procuring regulatory clearances to broaden their scope to new therapeutic applications. This pertains to formal approvals by government bodies that permit the marketing and prescription of a drug for certain medical conditions, contingent on its assessed safety, effectiveness, and quality. For example, in November 2022, the US-based government agency, known as the Food and Drug Administration, gave Kineret (anakinra) the Emergency Use Authorization (EUA) to be used as a treatment for adults hospitalized with COVID-19-related pneumonia who require supplemental oxygen. This was done with the intention of diminishing the risk of serious respiratory failure. The permission was contingent upon the SAVE-MORE phase 3 study, which noted that early intervention with Kineret enhanced patient results. Kineret functions by obstructing cytokines IL-1a and IL-1ß, proteins that exacerbate the rampant inflammatory reaction seen in severe cases of COVID-19. While Kineret has not yet achieved full FDA approval for this specific use, it has been given the green light for temporary usage amid the public health crisis._x000D_

_x000D_

#Who Are The Main Participants Shaping The Cannabis Capsule Market Landscape?#_x000D_

Major companies operating in the anakinra market are Swedish Orphan Biovitrum AB, Boehringer Ingelheim, Amgen Inc. _x000D_

_x000D_

https://www.thebusinessresearchcompany.com/report/anakinra-global-market-report_x000D_

_x000D_

#Which Region Currently Holds The Largest Share In The Cannabis Capsule Market?#_x000D_

North America was the largest region in the anakinra market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anakinra market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=21095&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_